Return On Assets of Context Therapeutics Inc. from 30 Jun 2022 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Context Therapeutics Inc. quarterly and annual Return On Assets in % history and change rate from 30 Jun 2022 to 30 Sep 2025.
  • Context Therapeutics Inc. Return On Assets for the quarter ending 30 Sep 2025 was -30%, a 47% increase year-over-year.
  • Context Therapeutics Inc. annual Return On Assets for 2024 was -36%, a 63% increase from 2023.
  • Context Therapeutics Inc. annual Return On Assets for 2023 was -97%, a 181% decline from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Context Therapeutics Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -30% +26% +47% 01 Jul 2025 30 Sep 2025
Q2 2025 -38% +11% +23% 01 Apr 2025 30 Jun 2025
Q1 2025 -29% +80% +73% 01 Jan 2025 31 Mar 2025
Q4 2024 -36% +61% +63% 01 Oct 2024 31 Dec 2024
Q3 2024 -56% +13% +19% 01 Jul 2024 30 Sep 2024
Q2 2024 -49% +5% +9.3% 01 Apr 2024 30 Jun 2024
Q1 2024 -110% -64% -142% 01 Jan 2024 31 Mar 2024
Q4 2023 -97% -62% -181% 01 Oct 2023 31 Dec 2023
Q3 2023 -69% -38% -122% 01 Jul 2023 30 Sep 2023
Q2 2023 -54% -21% -63% 01 Apr 2023 30 Jun 2023
Q1 2023 -45% 01 Jan 2023 31 Mar 2023
Q4 2022 -35% 01 Oct 2022 31 Dec 2022
Q3 2022 -31% 01 Jul 2022 30 Sep 2022
Q2 2022 -33% 01 Apr 2022 30 Jun 2022

Context Therapeutics Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -36% +61% +63% 01 Jan 2024 31 Dec 2024
2023 -97% -62% -181% 01 Jan 2023 31 Dec 2023
2022 -35% 01 Jan 2022 31 Dec 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.